Metabolically inactive insulin analog prevents type I diabetes in prediabetic NOD mice.

Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin.

1991 • 562 citations

Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23).

1996 • 415 citations

Monomeric Insulins and Their Experimental and Clinical Implications

1990 • 374 citations

Epitope specificity, cytokine production profile and diabetogenic activity of insulin‐specific T cell clones isolated from NOD mice

1995 • 359 citations

Major Histocompatibility Complex Class I-Deficient NOD-B2mnull Mice are Diabetes and Insulitis Resistant

1994 • 301 citations

Insulitis and Diabetes in NOD Mice Reduced by Prophylactic Insulin Therapy

1990 • 296 citations

Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription.

1995 • 248 citations

Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E.

1995 • 160 citations

Genetic and pathogenic basis of autoimmune diabetes in NOD mice

1994 • 136 citations

Analysis of the Spontaneous T Cell Response to Insulin in NOD Mice

1994 • 101 citations

High-Glucose Stimulation of 64,000-Mr Islet Cell Autoantigen Expression

1989 • 98 citations

Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy

1990 • 97 citations

Receptor Binding and Tyrosine Kinase Activation by Insulin Analogues With Extreme Affinities Studied in Human Hepatoma HepG2 Cells

1991 • 94 citations

Dependence of Antigen Expression on Functional State of β-Cells

1990 • 92 citations

Major histocompatibility complex class I-deficient NOD-B2mnull mice are diabetes and insulitis resistant

1994 • 89 citations

Autoantibodies in Nonobese Diabetic Mice Immunoprecipitate 64,000-Mr Islet Antigen

1988 • 86 citations

In Vitro and In Vivo Potency of Insulin Analogues Designed for Clinical Use

1991 • 74 citations

Molecular Mimicry Between Insulin and Retroviral Antigen p73: Development of Cross-Reactive Autoantibodies in Sera of NOD and C57BL/KsJ db/db Mice

1988 • 68 citations

Recognition of Common Islet Antigen by Autoantibodies From NOD Mice and Humans With IDDM

1990 • 58 citations

High-glucose stimulation of 64,000-Mr islet cell autoantigen expression

1989 • 44 citations

Autoantibodies in nonobese diabetic mice immunoprecipitate 64,000-Mr islet antigen

1988 • 40 citations

Insulin-specific human T cells. Epitope specificity, major histocompatibility complex restriction, and alloreactivity to a diabetes-associated haplotype.

1987 • 26 citations

Molecular mimicry between insulin and retroviral antigen p73. Development of cross-reactive autoantibodies in sera of NOD and C57BL/KsJ db/db mice

1988 • 25 citations

Comparative Study of the Protective Effect Afforded by Intravenous Administration of Bovine or Ovine Insulin to Young NOD Mice

1995 • 23 citations

Receptor binding and tyrosine kinase activation by insulin analogues with extreme affinities studied in human hepatoma HepG2 cells

1991 • 19 citations

Effect of Initiation of Insulin Therapy on T‐lymphocyte Activation in Type 1 Diabetes

1990 • 16 citations

The human immune response to insulin. I. Kinetic and cellular aspects of lymphocyte proliferative responses in diabetics.

1983 • 15 citations

In Vitro Control of T-Lymphocyte Insulin Receptors by In Vivo Modulation of Insulin

1983 • 12 citations

Comparative study of the protective effect afforded by intravenous administration of bovine or ovine insulin to young NOD mice

1995 • 9 citations